FDA: Avastin not safe or effective for breast cancer patients

The Food and Drug Administration announced its decision today to revoke the approval of the drug bevacizumab (Avastin) for treatment of metastatic breast cancer, which works by preventing new blood vessels from forming, starving a tumor of its blood supply....

Source: http://news.consumerreports.org/health/2011/11/fda-avastin-not-safe-or-effective-for-breast-cancer-patients.html

lamictal rash treatment bipolar medication lamictal lamictal half life lamictal